MarketPeel
Insider Trading Intelligence
Pricing
…
RW

Richard M. Wright

CLDX
SR. VP & CCO · CELLDEX THERAPEUTICS, INC. · CIK 0001646423
FILING MIX · LIFETIME48%/52%
BUYS
14
SELLS
15
TOTAL VALUE
$5.98M
COMPANIES
1
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
70,131
AVG SELL PX
$28.18
TRADE KIND
SHOWING 29 / 29
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
6 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Richard M. Wright, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d6+50.00%-1.50%-0.16%-1.35%-1.95%—
14d6+50.00%-0.24%+1.22%-1.47%-2.95%—
30d6+50.00%+0.70%+2.05%-1.34%-2.92%—
60d6+16.67%+11.03%+1.00%+10.03%+3.70%—
90d6+16.67%+20.31%+4.68%+15.63%+16.34%—
180d6+33.33%+25.87%+11.68%+14.19%+22.53%—
1y6(1 pending)+60.00%+22.69%+18.28%+4.41%-21.30%—
2y6(1 pending)+60.00%+41.50%+18.72%+57.07%+107.92%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CLDX · 70,131 shares · as of Nov 13, 2025
017,53335,06652,59870,13120212022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
FLOW · 14 buys / 15 sellsCOVERAGE · 23 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CLDX
CELLDEX THERAPEUTICS, INC.
SALE
15,750——7,875Nov 13, 2025Nov 17, 2025 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
PURCHASE
6,876$9.02$62.0K27,709Nov 13, 2025Nov 17, 2025 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
SALE
6,876——0Nov 13, 2025Nov 17, 2025 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
SALE
26,672——0Nov 13, 2025Nov 17, 2025 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
SALE
49,298$24.00$1.18M20,833Nov 13, 2025Nov 17, 2025 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
PURCHASE
26,672$10.38$276.9K54,381Nov 13, 2025Nov 17, 2025 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
PURCHASE
15,750$22.48$354.1K70,131Nov 13, 2025Nov 17, 2025 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
65,000——65,000Jun 13, 2024Jun 17, 2024 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
PURCHASE
SR. VP & CCO
18,375$22.48$413.1K67,677Jun 3, 2024Jun 5, 2024 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
SALE
SR. VP & CCO
19,264$33.99$654.7K20,833Jun 3, 2024Jun 5, 2024 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
SALE
SR. VP & CCO
18,375——23,625Jun 3, 2024Jun 5, 2024 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
PURCHASE
SR. VP & CCO
28,469$28.00$797.1K49,302Jun 3, 2024Jun 5, 2024 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
SALE
SR. VP & CCO
28,469——13,531Jun 3, 2024Jun 5, 2024 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
SALE
SR. VP & CCO
27,580$33.53$924.7K40,097Jun 3, 2024Jun 5, 2024 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
PURCHASE
SR. VP & CCO
20,625$2.78$57.3K20,833Jun 3, 2024Jun 5, 2024 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
SALE
SR. VP & CCO
20,625——0Jun 3, 2024Jun 5, 2024 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
45,000——45,000Jun 15, 2023Jun 20, 2023 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
SALE
SR. VP & CCO
15,328$37.71$578.0K208Aug 15, 2022Aug 17, 2022 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
SALE
SR. VP & CCO
15,328——26,672Aug 15, 2022Aug 17, 2022 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
PURCHASE
SR. VP & CCO
15,328$10.38$159.1K15,536Aug 15, 2022Aug 17, 2022 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
42,000——42,000Jun 16, 2022Jun 17, 2022 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
42,000——42,000Jun 17, 2021Jun 21, 2021 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
SALE
Sr. VP & CCO
11,457——6,876Dec 14, 2020Dec 16, 2020 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
SALE
Sr. VP & CCO
9,375$18.61$174.4K208Dec 14, 2020Dec 16, 2020 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
SALE
Sr. VP & CCO
9,375——20,625Dec 14, 2020Dec 16, 2020 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
PURCHASE
Sr. VP & CCO
9,375$2.78$26.1K9,583Dec 14, 2020Dec 16, 2020 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
SALE
Sr. VP & CCO
11,457$18.61$213.2K208Dec 14, 2020Dec 16, 2020 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
PURCHASE
Sr. VP & CCO
11,457$9.02$103.3K11,665Dec 14, 2020Dec 16, 2020 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
42,000——42,000Jun 18, 2020Jun 19, 2020 ↗View →
Other insiders · CLDX
Loading peer insiders…
About this filer
CIK 0001646423
ROLE
Sr. VP & CCO
PRIMARY
CLDX
COMPANIES
1
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001646423DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback